The European Medicines Agency (EMEA) said it wants the marketer of the adult smoking cessation prescription drug Champix (varenicline) to update the patient and doctor information to mention that some patients on the drugs have been having suicidal thoughts and made attempts to kill themselves.The European Commission (EC) authorized Champix, marketed by drug company Pfizer, in September 2006. [click link for full article]
Popularity: 1% [?]
Related posts:
- Europe Wants Warnings On Champix Smoking Cessation Drug
- European Medicines Agency Concludes New Advice To Doctors And Patientsfor Champix Needed
- European Medicines Agency Concludes New Advice To Doctors And Patientsfor Champix Needed
- Suicide Behavior FDA Public Health Advisory For Chantix – Smoking Cessation Drug
- No Link Between Smoking Cessation Drug And Increased Risk Of Self Harm Or Depression
Comments
No Responses to “Europe Wants Warnings On Champix Smoking Cessation Drug”